FDA發(fā)布經石棉測試的含滑石粉化妝品的最終報告(2020.3.9)

美國食品藥品監(jiān)督管理局（FDA）發(fā)布了一項測試，結果表明抽樣的含滑石粉的化妝品中有17％含有石棉纖維。

該結果由FDA在3月9日發(fā)布，是在該機構進行了長達一年的努力之后，對經過挑選的一部分含滑石粉的化妝品進行了測試，以確定它們是否含有石棉。調查結果顯示，有43個樣本為陰性，有9個為陽性。

當確實發(fā)現(xiàn)石棉的存在時，應當立即通知公眾該產品，并與受影響的公司合作進行召回。盡管結果存在爭議，但根據(jù)FDA的調查結果，一些行業(yè)巨頭都自愿召回了相關產品。

FDA表示，它將在來年選擇另外的50個樣品進行盲測，最終結果將于2021年初發(fā)布。對于任何陽性檢測，F(xiàn)DA將再次“將結果告知公眾，并將與相關公司將受影響的產品從市場上下架。

“The FDA is committed to keeping consumers safe from potentially contaminated cosmetic products. As part of this effort, in September 2018, the agency awarded AMA Analytical Services, Inc. (AMA) a one-year contract to test certain talc-containing cosmetic products for the presence of asbestos. We have taken and will continue to take swift action when we determine a cosmetic product is not safe.

“There is general agreement among U.S. federal agencies and the World Health Organization that there is no known safe level of asbestos exposure. Earlier this month during a public meeting, the FDA gathered input from federal partners, industry experts and the public to support the development of standardized testing, methodologies, terminology and criteria that can be applied to characterize and measure asbestos and other potentially harmful elongate mineral particles that may be present as contaminants in talc-containing products or products that use talc as an ingredient. Our work in this area is ongoing and we’ll continue to communicate with the public as we have updates to share.” 

• The U.S. Food and Drug Administration today issued the AMA Analytical Services, Inc. final report in six parts from the agency’s year-long sampling assignment to test talc-containing cosmetic products for the presence of asbestos.
• The full results showed 43 samples were negative and 9 were positive for asbestos. 
• Last year, the FDA immediately notified the public about the positive results and worked closely with the affected companies on their subsequent recalls. This final report lists both the positive and negative results of the talc-containing cosmetic products tested by AMA in 2019. 
• The FDA will conduct another talc sampling assignment throughout 2020, with 50 additional samples selected for blinded testing by AMA and will communicate any positive results if found. The final results are expected to be released in early 2021.